Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Chronic kidney disease

RAAS blockade and diastolic heart failure in chronic kidney disease

New data from Ahmed et al. show that discharge prescriptions for renin–angiotensin–aldosterone inhibitor therapy are associated with a significant reduction in all-cause mortality in elderly patients with diastolic heart failure and chronic kidney disease (CKD). These observational data support the case for prospective studies of RAAS blockade in patients with CKD and diastolic heart failure.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Ahmed, A. et al. Renin-angiotensin inhibition in diastolic heart failure and chronic kidney disease. Am. J. Med. 126, 150–161 (2013).

    Article  CAS  Google Scholar 

  2. Tonelli, M. et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet 380, 807–814 (2012).

    Article  Google Scholar 

  3. Rakhit, D. J. et al. Prognostic role of subclinical left ventricular abnormalities and impact of transplantation in chronic kidney disease. Am. Heart J. 153, 656–664 (2007).

    Article  Google Scholar 

  4. Pecoits-Filho, R. et al. Diastolic heart failure in dialysis patients: Mechanisms, diagnostic approach and treatment. Semin. Dial. 25, 35–41 (2012).

    Article  Google Scholar 

  5. Liu, S. S., Monti, J., Kargbo, H. M., Athar, M. W. & Parakh, K. Frontiers of therapy for patients with heart failure. Am. J. Med. 126, 6–12 (2013).

    Article  CAS  Google Scholar 

  6. Ahmed, A. et al. Renin–angiotensin inhibition in systolic heart failure and chronic kidney disease. Am. J. Med. 125, 399–410 (2012).

    Article  CAS  Google Scholar 

  7. Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO Clinical Practical Guideline for the management of blood pressure in chronic kidney disease. Kidney Int. Suppl. 2, 337–414 (2012).

  8. Lambers Heerspink, H. J. et al. Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers. Kidney Int. 82, 330–337 (2012).

    Article  Google Scholar 

  9. Vegter, S. et al. Sodium intake, ACE inhibition, and progression to ESRD. J. Am. Soc. Nephrol. 23, 165–173 (2012).

    Article  CAS  Google Scholar 

  10. Holtkamp, F. A. et al. An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function. Kidney Int. 80, 282–287 (2011).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gerjan Navis.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Franssen, C., Navis, G. RAAS blockade and diastolic heart failure in chronic kidney disease. Nat Rev Nephrol 9, 190–192 (2013). https://doi.org/10.1038/nrneph.2013.39

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2013.39

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing